ATRIAL FIBRILLATION, WEARABLE TECHNOLOGIES AND ARTIFICIAL INTELLIGENCE: CURRENT EVIDENCE, CLINICAL UTILITY AND LIMITATIONS
Authors:
- Radosław KołodziejRKRadosław Kołodziej
- Kacper SzpanelewskiKSKacper Szpanelewski
- Jakub KlechaJKJakub Klecha
- Joanna CiemięGaJCJoanna CiemięGa
- Anna KołodziejAKAnna Kołodziej
- Szczepan PółchłopekSPSzczepan Półchłopek
- Szymon LulekSLSzymon Lulek
- Izabella KulaIKIzabella Kula
- Emilia KucabEKEmilia Kucab
- Damian DanilczukDDDamian Danilczuk
- Katarzyna DzikiKDKatarzyna Dziki
- Wiktor AdamiecWAWiktor Adamiec
Open Access
- 22 September 2026
- journal article
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (3(51))
Abstract
Background: Atrial fibrillation is the most common sustained cardiac arrhythmia in adults and represents an important clinical and public health problem because of its association with stroke, mortality, disability, and healthcare burden. Its paroxysmal and frequently asymptomatic course limits the effectiveness of conventional diagnostic strategies based on occasional electrocardiographic recordings. Aim: This narrative review aims to summarise current evidence regarding the use of wearable technologies and artificial intelligence for the detection of atrial fibrillation, with particular emphasis on diagnostic accuracy, clinical utility, and principal limitations. Methods: A structured literature search was performed using PubMed, Scopus, Web of Science, and Google Scholar. Studies published between 2021 and 2026 were primarily considered. Search terms included “atrial fibrillation,” “wearable technologies,” “smartwatch,” “electrocardiography,” “photoplethysmography,” “artificial intelligence,” “machine learning,” and “diagnostics.” Priority was given to original studies, systematic reviews, meta-analyses, and clinically relevant review articles concerning wearable devices, artificial intelligence, and atrial fibrillation detection. Earlier landmark studies were included when they were necessary to explain key evidence discussed in recent reviews and meta-analyses. Results: Wearable devices such as smartwatches, fitness bands, and portable ECG systems allow longer heart rhythm monitoring in daily life and may help detect paroxysmal and clinically silent atrial fibrillation. ECG-based devices are more consistent with current diagnostic standards, whereas photoplethysmography-based systems are more accessible and can provide passive rhythm monitoring. Artificial intelligence, especially machine learning and deep learning, can support signal interpretation, arrhythmia recognition, and risk prediction. However, diagnostic performance reported in controlled studies may not always translate directly into real-world clinical practice. Conclusions: Wearable technologies and artificial intelligence offer a promising way to support atrial fibrillation screening and monitoring. They may improve early detection, especially in asymptomatic individuals, but should not replace standard diagnostic methods. Photoplethysmography-based alerts should be regarded as screening signals, while a final diagnosis of atrial fibrillation should still be confirmed by ECG in an appropriate clinical context. More large-scale studies are needed before these tools can be widely implemented in routine practice.Keywords
This publication has 19 references indexed in Scilit:
- Artificial intelligence in atrial fibrillation – Timely diagnosis, risk assessment and personalized managementIndian Pacing and Electrophysiology Journal, 2026
- Accuracy of Smartwatches in the Detection of Atrial FibrillationJACC: Advances, 2025
- Recent advances in the tools and techniques for AI-aided diagnosis of atrial fibrillationBiophysics Reviews, 2025
- Photoplethysmography based atrial fibrillation detection: a continually growing fieldPhysiological Measurement, 2024
- Atrial fibrillation and strokeExpert Review of Cardiovascular Therapy, 2023
- Use of digital health applications for the detection of atrial fibrillationHerzschrittmachertherapie + Elektrophysiologie, 2022
- Mobile health technology in atrial fibrillationExpert Review of Medical Devices, 2022
- Diagnostic accuracy of smart gadgets/wearable devices in detecting atrial fibrillation: A systematic review and meta-analysisArchives of Cardiovascular Diseases, 2021
- Corrigendum to: 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS)European Heart Journal, 2020
- Large-Scale Assessment of a Smartwatch to Identify Atrial FibrillationNew England Journal of Medicine, 2019